Ilgan S[au] - Search Results

Year	Number of Results
1998	4
1999	9
2000	4
2001	4
2002	1
2003	2
2004	5
2005	4
2006	3
2007	6
2008	1
2009	3
2010	3
2012	1
2014	2
2016	2
2020	1
2023	3
2024	2

1

The sonographer's and pathologist's perspective of echogenic microfoci in papillary thyroid carcinoma.

Bahçecioğlu AB, Gürsoy A, Dizbay Sak S, Ilgan S, Bilezikçi B, Erdoğan MF. Bahçecioğlu AB, et al. Among authors: ilgan s. Eur Thyroid J. 2023 Dec 28;12(6):e230108. doi: 10.1530/ETJ-23-0108. Print 2023 Dec 1. Eur Thyroid J. 2023. PMID: 37992287 Free PMC article.

2

Unusual patterns of I-131 accumulation.

Ozguven M, Ilgan S, Karacalioglu AO, Arslan N, Ozturk E. Ozguven M, et al. Among authors: ilgan s. Clin Nucl Med. 2004 Nov;29(11):738-40. doi: 10.1097/00003072-200411000-00020. Clin Nucl Med. 2004. PMID: 15483496 No abstract available.

3

Schwannomatozis of the Chest Wall: FDG PET Findings.

Ilgan S, Dikmen E, Cetinkanat CG, Dakak M, Güngör A. Ilgan S, et al. Mol Imaging Radionucl Ther. 2014 Jun;23(2):64-6. doi: 10.4274/mirt.353. Epub 2014 Jun 5. Mol Imaging Radionucl Ther. 2014. PMID: 24963448 Free PMC article.

4

Exceptionally Rare Isolated Thyroidal Metastasis of Pulmonary Carcinosarcoma: A Tale of ¹⁸F-FDG-positive Thyroid Nodule.

Mavi ME, Amini F, Ilgan S. Mavi ME, et al. Among authors: ilgan s. Mol Imaging Radionucl Ther. 2024 Feb 22;33(1):63-65. doi: 10.4274/mirt.galenos.2023.74507. Mol Imaging Radionucl Ther. 2024. PMID: 38390824 Free PMC article.

5

Imaging tumor folate receptors using 111In-DTPA-methotrexate.

Ilgan S, Yang DJ, Higuchi T, Zareneyrizi F, Kim EE, Podoloff DA. Ilgan S, et al. Cancer Biother Radiopharm. 1998 Jun;13(3):177-84. doi: 10.1089/cbr.1998.13.177. Cancer Biother Radiopharm. 1998. PMID: 10850353

6

Warthin's tumor and I-131 body scan.

Ilgan S, Narin Y, Arslan N, Aksu A, Bayhan H. Ilgan S, et al. Clin Nucl Med. 1999 Sep;24(9):721-2. doi: 10.1097/00003072-199909000-00029. Clin Nucl Med. 1999. PMID: 10478764 No abstract available.

7

Early Dynamic Risk Stratification Decreases Rate of Ablative and Adjuvant Radioiodine Use in ATA Low and Intermediate Risk Papillary Thyroid Cancer Patients.

Gorur SK, Ozbas S, Ilgan S. Gorur SK, et al. Among authors: ilgan s. Sisli Etfal Hastan Tip Bul. 2023 Dec 29;57(4):451-457. doi: 10.14744/SEMB.2023.97415. eCollection 2023. Sisli Etfal Hastan Tip Bul. 2023. PMID: 38268648 Free PMC article.

8

Unusual patterns of I-131 contamination.

Ozguven M, Ilgan S, Arslan N, Karacalioglu AO, Yuksel D, Dundar S. Ozguven M, et al. Among authors: ilgan s. Ann Nucl Med. 2004 May;18(3):271-4. doi: 10.1007/BF02985010. Ann Nucl Med. 2004. PMID: 15233290

9

Differentiation of Benign and Malignant Thyroid Nodules with ANFIS by Using Genetic Algorithm and Proposing a Novel CAD-Based Risk Stratification System of Thyroid Nodules.

Ozturk AC, Haznedar H, Haznedar B, Ilgan S, Erogul O, Kalinli A. Ozturk AC, et al. Among authors: ilgan s. Diagnostics (Basel). 2023 Feb 15;13(4):740. doi: 10.3390/diagnostics13040740. Diagnostics (Basel). 2023. PMID: 36832228 Free PMC article.

10

Sonographic Features of Atypical and Initially Missed Parathyroid Adenomas: Lessons Learned From a Single-Center Cohort.

Ilgan S, Aydoğan Bİ, Emer Ö, Anıl C, Gürsoy A, Cesur M, Bilezikçi B. Ilgan S, et al. J Clin Endocrinol Metab. 2024 Jan 18;109(2):439-448. doi: 10.1210/clinem/dgad527. J Clin Endocrinol Metab. 2024. PMID: 37668359

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

59 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

59 results

Results by year